Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

DANAHER CORPORATION

(DHR)
  Report  
Delayed Quote. Delayed Nyse - 05/17 04:00:49 pm
131.1 USD   -0.88%
05/08DANAHER : to Present at Bank of America Merrill Lynch Health Care Conference
PR
05/07DANAHER : Announces Quarterly Dividend
PR
04/25DANAHER : Announces Quarterly Dividend
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Danaher : Cuts Fiscal Year Targets, Gives 2Q Outlook

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/18/2019 | 06:45am EDT

By Kimberly Chin

Danaher has cut its full-year 2019 guidance to reflect the dilution regarding its equity offering to fund its $21.4 billion acquisition of General Electric Co.'s (GE) GE BioPharma.

For the year, Danaher now anticipates earnings of $3.34 to $3.42 a share, down from its previous forecast of $3.85 to $3.95. It expects adjusted profit of $4.72 to $4.80, a cut from its prior guidance of $4.75 to $4.85. Analysts polled by Refinitiv were expecting full-year earnings of $3.98 a share and adjusted earnings of $4.79 a share.

For the current quarter, the company projects earnings between 89 cents and 92 cents a share and adjusted earnings between $1.13 and $1.16 a share. Analysts expect earnings of 99 cents a share and adjusted earnings of $1.19 a share for the second quarter.

Shares of Danaher, which has gained 21% for the year, were mostly flat in premarket trading on low trading volumes.

Write to Kimberly Chin at kimberly.chin@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
DANAHER CORPORATION -0.88% 131.1 Delayed Quote.27.13%
GENERAL ELECTRIC COMPANY -1.28% 10 Delayed Quote.32.10%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DANAHER CORPORATION
05/08DANAHER CORP /DE/ : Submission of Matters to a Vote of Security Holders (form 8-..
AQ
05/08DANAHER : to Present at Bank of America Merrill Lynch Health Care Conference
PR
05/07DANAHER : Announces Quarterly Dividend
PR
04/25DANAHER : Announces Quarterly Dividend
PU
04/18DANAHER : Cuts Fiscal Year Targets, Gives 2Q Outlook
DJ
04/18DANAHER : Profit Falls on Higher Taxes, Costs
DJ
04/18DANAHER : 1Q Earnings Snapshot
AQ
04/18DANAHER : DE/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
04/18DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Sta..
AQ
04/18DANAHER : Reports First Quarter 2019 Results
PR
More news
Financials ($)
Sales 2019 20 626 M
EBIT 2019 4 385 M
Net income 2019 2 640 M
Debt 2019 3 987 M
Yield 2019 0,51%
P/E ratio 2019 36,95
P/E ratio 2020 30,29
EV / Sales 2019 4,74x
EV / Sales 2020 4,60x
Capitalization 93 859 M
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 142 $
Spread / Average Target 8,2%
EPS Revisions
Managers
NameTitle
Thomas Patrick Joyce President, Chief Executive Officer & Director
Steven M. Rales Chairman
Matthew R. McGrew Chief Financial Officer
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER CORPORATION27.13%93 859
THERMO FISHER SCIENTIFIC16.95%104 687
INTUITIVE SURGICAL2.34%56 586
BOSTON SCIENTIFIC CORPORATION5.60%51 899
ILLUMINA2.57%45 222
SIEMENS HEALTHINEERS AG0.97%41 173